Get started
Author

Angelo Gambi

Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. Italian Multicentre Breast Study with Epirubicin.
1988 · G Ambrosini, M Balli, et al. · Journal of Clinical Oncology · 168
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial
2018 · Sabino De Placido, Ciro Gallo, et al. · The Lancet Oncology · 93
Disease-Free Survival Advantage of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Patients With Node-Negative, Rapidly Proliferating Breast Cancer: A Randomized Multicenter Study
2000 · Dino Amadori, Oriana Nanni, et al. · Journal of Clinical Oncology · 56
Role of biological markers in the clinical outcome of colon cancer
2002 · O Nanni, A Volpi, et al. · British Journal of Cancer · 51
PDF
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX
2017 · Jean-François Emile, Catherine Julié, et al. · European Journal of Cancer · 49
Smoking habits, exposure to passive smoking and attitudes to a non-smoking policy among hospital staff
1998 · F Zanetti, A Gambi, et al. · Public Health · 45
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial
2021 · Gerardo Rosati, Sara Lonardi, et al. · European Journal of Cancer · 16
A Cross Sectional Survey on Breast Self Examination Practice, Utilization of Breast Professional Examination, Mammography and Associated Factors in Romagna, Italy
1992 · Salvatore Ferro, Annalisa Caroli, et al. · Tumori Journal · 15
Epirubicin Followed by Cyclophosphamide, Methotrexate and 5-Fluorouracil versus Paclitaxel Followed by Epirubicin and Vinorelbine in Patients with High-Risk Operable Breast Cancer
2010 · Francesco Boccardo, Dino Amadori, et al. · Oncology · 14
Phase III randomized multicenter study on the effects of adjuvant CMF in patients with node-negative, rapidly proliferating breast cancer: twelve-year results and retrospective subgroup analysis
2007 · Dino Amadori, Oriana Nanni, et al. · Breast Cancer Research and Treatment · 11
Tobacco Smoking among High School Students in Romagna (Italy) and Evaluation of a Prevention Campaign
2000 · Anna Bergamaschi, Angelo Gambi, et al. · Substance Use & Misuse · 11
A Randomized Trial on Breast Self-Examination in Faenza (Northern-Italy)
1996 · Salvatore Ferro, Annalisa Caroli, et al. · Tumori Journal · 7
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset
2015 · Josef Thaler, Richard Greil, et al. · Annals of Oncology · 4
Inadequate Follow up for Abnormal Cervical Smears
1994 · Angelo Gambi, Nadia Grilli, et al. · Journal of Medical Screening · 2
Risk factors for clinically diagnosed patients of Alzheimer??s disease: A case-control study of an Italian population
1987 · LA Amaducci, L Fratiglioni, et al. · Alzheimer Disease & Associated Disorders · 2
Prospective use of tumor proliferative activity for adjuvant therapy in node-negative breast cancer patients
1997 · D. Amadori, Annalisa Volpi, et al. · Florence Research (University of Florence) · 1
Epirubicin (E) followed by cyclophosphamide, methotrexate, 5-fluorouracil (CMF) versus paclitaxel (T) followed by epirubicin and vinorelbine (EV) in patients (pts) with high-risk operable breast cancer
2009 · F. Boccardo, A. Rubagotti, et al. · Journal of Clinical Oncology
Adjuvant CMF for patients with node-negative, rapidly proliferating breast cancer.
2000 · D. Amadori, Annalisa Volpi, et al. · Florence Research (University of Florence)
[A proposal for monitoring smoking prevention programs with the use of indicators].
1997 · F Focarile, S Ferro, et al. · PubMed
Works count: 21
Citation count: 545
H-index: 11
I10-index: 11
Year
Topic
Type